Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IG Has Overly “Negative” View Of Sales Incentives, Pfizer Counsel Says

Executive Summary

The HHS Inspector General's draft compliance guidance for the pharmaceutical industry takes an overly "negative" stance on compensation for sales representatives, Pfizer Corporate Compliance Counsel Doug Lankler said
Advertisement

Related Content

PhRMA Marketing Code Is Shifting Promotional Budgets To CME
Pfizer To Audit Managed Care Grants Under Lipitor “Best Price” Settlement
PhRMA Marketing Code Is Shifting Promotional Budgets To CME
IG Rx Compliance Guide Sets PhRMA Marketing Code As Minimum Threshold
IG Rx Compliance Guide Sets PhRMA Marketing Code As Minimum Threshold
Lilly Takes Separate Track On IG; Compliance Guide Is Not A PhRMA Issue
Advertisement
UsernamePublicRestriction

Register

PS040730

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel